Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Bevacizumab

Ileal neobladder perforation: case report

    • 13 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Liu SV, Gollard R, Iqbal S.Case report of perforation of an ileal neobladder after treatment of rectal cancer with bevacizumab and comment on mechanisms of intestinal perforation associated with bevacizumab. Journal of Clinical Pharmacy and Therapeutics 37: 607-609, No. 5, Oct 2012. Available from: URL: http://dx.doi.org/10.1111/j.1365-2710.2012.01343.x - USA

    Download references

    Additional information

    Key words

    adverse reactions; Bevacizumab; drug-induced; Bladder-disorders

    An event is serious (FDA MedWatch definition) when the patient outcome is: death; life-threatening; hospitalisation; disability; congenital anomaly; requires intervention to prevent permanent impairment or damage

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Bevacizumab. React. Wkly. 1426, 13 (2012). https://doi.org/10.2165/00128415-201214260-00046

    Download citation

    Keywords

    • Catheter
    • Abdominal Pain
    • Rectal Cancer
    • Bevacizumab
    • Ileal